State Medicaid Programs Wasting Tens of Millions on Drugging Children
State Medicaid programs are spending tens of millions of dollars on psychoactive drugs for children that do not work, damage brains, cause diabetes, and produce drug dependent zombies out of innocent children.
Look at the statistics for several of the newer “atypical” antipsychotics like
Seroquel, Abilify, Geodon, Risperdal and Zyprexa.
These are examples of what Florida Medicaid paid on kids only, 18 and under, for the last 5 years. Geodon, Seoquel and Zyprexa have ZERO FDA approved uses for children.
Abilify |
2003 |
$1,539,509.55 |
Abilify |
2004 |
$5,359,775.43 |
Abilify |
2005 |
$8,579,480.93 |
Abilify |
2006 |
$10,090,910.44 |
Abilify |
2007 |
$10,271,082.29 |
Geodon |
2003 |
$904,035.19 |
Geodon |
2004 |
$1,187,428.90 |
Geodon |
2005 |
$1,189,068.28 |
Geodon |
2006 |
$1,484,866.82 |
Geodon |
2007 |
$1,722,867.61 |
Risperdal |
2003 |
$8,301,415.13 |
Risperdal |
2004 |
$8,928,425.18 |
Risperdal |
2005 |
$8,855,072.01 |
Risperdal |
2006 |
$8,868,847.84 |
Risperdal |
2007 |
$9,509,060.26 |
Seroquel |
2003 |
$3,911,146.00 |
Seroquel |
2004 |
$5,608,500.30 |
Seroquel |
2005 |
$6,690,734.14 |
Seroquel |
2006 |
$7,414,643.93 |
Seroquel |
2007 |
$7,843,666.17 |
Zyprexa |
2003 |
$5,850,078.39 |
Zyprexa |
2004 |
$4,667,326.50 |
Zyprexa |
2005 |
$2,312,692.06 |
Zyprexa |
2006 |
$1,892,506.73 |
Zyprexa |
2007 |
$1,992,219.54 |
|
|
$134,975,359.62 |
This is $134,975,359 on children in Florida for drugs that have no FDA approved uses in children. Seroquel is on the FDA's warning list for potential safety problems.
Watch this informative video on Teen Screen and how it is a ploy by big pharma and the government to get your children on psychiatric drugs. Its very insidious and evil in my opinion. Once you watch this you'll see why.
http://www.youtube.com/watch?v=RfU9puZQKBY

Order Metal-Free Order Body Detox BodyHealth Complete+Detox
Order MAP Order BIC Order Pozitive Energy Order Healthy-Thin
Copyright © 2010 Optimum Health Report, All Rights Reserved. Disclaimer
|